Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Implantable Drug Firm Valera Gets $11.5M In Third Round

Aug. 23, 2004

By Aaron Lorenzo

ProlX In-Licenses Class Of Early Stage Cancer Drugs

Aug. 20, 2004

By Aaron Lorenzo

ProlX In-Licenses Class Of Early Stage Cancer Drugs

Aug. 20, 2004

By Aaron Lorenzo

CyDex Series B Nets $17M For Internal Drug Programs

Aug. 18, 2004

By Aaron Lorenzo

CyDex Series B Nets $17M For Internal Drug Programs

Aug. 18, 2004

By Aaron Lorenzo

Using Bacteria As Therapeutic, Osel Advancing Lead Product

Aug. 17, 2004

By Aaron Lorenzo

Ciphergen Test Shows Promise For Detection Of Ovarian Cancer

Aug. 17, 2004

By Aaron Lorenzo

Ciphergen Test Shows Promise For Detection Of Ovarian Cancer

Aug. 17, 2004

By Aaron Lorenzo

Using Bacteria As Therapeutic, Osel Advancing Lead Product

Aug. 17, 2004

By Aaron Lorenzo

Spectrum Deals For Rights To Clinical-Stage LHRH Antagonist

Aug. 13, 2004

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...